Penile Neoplasm — Trials

Penile Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

100 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 51–56 of 56 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01807546	Oral Rigosertib for Squamous Cell Carcinoma	completed	Phase 2	64	Traws Pharma, Inc.INDUSTRY	1	Jun 26, 2017	clinicaltrials
NCT02279576	Study With Pazopanib and Weekly Paclitaxel in Penile Carcinoma (PAZOPEN-SOGUG)(PAZOPEN-SOGUG)	terminated	Phase 2	4	Spanish Oncology Genito-Urinary GroupOTHER	1	Oct 14, 2016	clinicaltrials
NCT02014831	Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE)(PENILANE)	withdrawn	Phase 2	0	Centre Leon BerardOTHER	1	Feb 25, 2016	clinicaltrials
NCT00066391	Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer

Data updated 23 days agoSource updated Jun 26, 2017source: clinicaltrials